Dolon is a strategic pricing and market access consultancy specialising in rare diseases. With headquarters in London and staff located across Europe, we’re dedicated to accelerating access to life-saving treatments for patients all over the world.

Three core principles underpin our work:
 

1. Rare knowledge

We have in-depth knowledge of the pricing and reimbursement environment for rare disease treatments. We know the key stakeholders and how to communicate effectively about unmet need and the value of innovation in rare diseases.

2. Strategic thinking

Our strong research and analytic capabilities enable us to generate new insights and translate complex data into compelling evidence-based value messages and policy recommendations. From the technical details to the bigger picture, we help clients prioritise the issues, structure their thinking and formulate solutions to overcome market access challenges.

3. Collaborative partnership

We know that true success stems from collaboration. We’re proud to forge long-term partnerships with our clients based on mutual respect, flexibility and understanding.